News Focus
News Focus
icon url

flipper44

05/23/17 7:45 PM

#118751 RE: iclight #118749

Approximately 5 percent of patients with metastatic colorectal cancer have MSI-H or dMMR tumors. https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm560167.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery



People want to extend their lives for years, not just shrink their tumors for months, and if you are happy with 40% tumor response rates on 5% of solid tumors, then your work is done here. No need to see what comes next.
icon url

faraifarai

05/24/17 9:49 AM

#118804 RE: iclight #118749

totally, dude.
icon url

CherryTree1

05/24/17 10:52 AM

#118815 RE: iclight #118749

Where are you getting Overall Response Rates of 0 for DCVAX Direct ? ? ?
https://www.nwbio.com/dcvax-direct-trial-update-indicates-further-positive-responses-3-case-studies-show-no-live-tumor-cells-in-injected-tumors/

All 9 Out Of 9 Patients Who Have Reached 4 Injections Are Showing Tumor Cell Death, Tumor Shrinkage And/Or Stabilization Of Disease